Jackie Hunter PhD DSc CBE FBPharmacolS FMedSci

Board Director BenevolentAI at BenevolentAI; Board Chair Brainomix and the SBC

Summary

Jackie FMedSci is a highly experienced professional in the pharmaceutical industry, currently serving as a Director at BenevolentAI where AI technology is revolutionizing Pharma R&D processes.
With a background that includes leadership roles in global R&D organizations and as CEO of SMEs, Jackie FMedSci brings a wealth of expertise to the table.
Jackie FMedSci's contributions extend beyond the corporate world, holding positions as an experienced Non-Executive Director and charity Trustee, showcasing a commitment to both professional and philanthropic endeavors.
Education-wise, Jackie FMedSci pursued studies at Kings School and earned a BSc PhD from Royal Holloway, University of London, solidifying a strong academic foundation to complement practical experiences.
Beyond BenevolentAI, Jackie FMedSci has held pivotal leadership roles at various organizations, including CEO positions at OI Pharma Partners Ltd, BenevolentBio Ltd, and Stratified Medical Ltd.
Noteworthy roles in the pharmaceutical sector include executive positions at GlaxoSmithKline, where Jackie FMedSci served as Senior Vice President in various science and development capacities.
Currently, in addition to her role at BenevolentAI, Jackie FMedSci serves as the Chair of several Boards, including Brainomix Ltd and the Sainsbury lab at Norwich, UK, highlighting her multidimensional involvement in the industry.
Jackie FMedSci's career trajectory showcases a profound dedication to advancing pharmaceutical research and development, with a unique blend of executive leadership, AI technology integration, and strategic partnerships.
Throughout her distinguished career, Jackie FMedSci's contributions have made a lasting impact on the pharmaceutical landscape, positioning her as a prominent figure in the industry.